slides · global inventory
Table Data
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 16,285
Current window 6,691-6,720
Pages 543
Rows per page 30
Tool
6,691-6,720 of 16,285
12
The slide uses a highlighted column for Allego to emphasize its competitive positioning.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · Market Size1 hit
17
The slide uses a table format to list countries and their respective target years for ICE bans, alongside a callout for projected EV sales.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The table is segmented by region (European, North American, Asian) and lists specific brands/groups with their respective electrification percentage targets and target years.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
21
The slide uses a structured table format to map strategic pillars to specific market data points.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
44
The slide uses a comparison table structure to highlight strategic fit for two major clients.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
19
The slide uses a combination of qualitative value propositions and quantitative performance metrics to establish credibility.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Solution & Approach1 hit
25
Includes segment-level breakdown for AOS Manufacturing, Outdoor Online Marketplace, and Corporate.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
26
Includes a footnote regarding excise taxes.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
17
Includes Kaplan-Meier survival curve and comparative efficacy tables.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
14
Includes specific clinical metrics (ORR, mPFS, mOS) comparing patients above and below the Minimal Efficacious Concentration (MEC).Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
The slide includes two scatter plots with error bars and two summary tables of experimental data.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
The slide includes detailed footnotes explaining specific adverse events and patient outcomes.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
24
Includes footnotes comparing results to historical METEOR and CANTATA studies.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
25
Data compares low vs high biomarker groups across different dosage cohorts.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
30
Data cutoff date is August 18, 2022. N=21 patients.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
31
Includes a footnote comparing results to a historical P3 study.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
33
Data shows a clear correlation between achieving MEC and better clinical outcomes in PDAC patients.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization to show progress through Preclinical, Phase 1, and Phase 2 stages for multiple assets.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
The table includes demographic, metabolic, inflammatory, and fibrosis markers.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
26
The slide uses bar charts to show dose-dependent increases in metabolic markers and a table to show pathway enrichment scores.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
39
The slide includes a prominent callout box summarizing the clinical significance of the baseline data.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
51
The slide uses a dark sidebar for context and a white main area for data presentation. It includes a citation at the bottom.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
55
The table compares Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID groups.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
03
The slide compares the Turquoise Hill benchmark against the Rio Tinto proposal across various financial and structural dimensions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
15
The slide shows a waterfall-style calculation of NAVPS, starting from Oyu Tolgoi NPV down to TRQ's final NAVPS in both USD and CAD.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
16
The chart compares target prices from five different financial institutions (Eight, Canaccord, Scotia, Macquarie, TD) with their respective recommendations and dates.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
Includes detailed footnotes explaining the methodology for WACC and beta calculations.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
19
The slide presents two tables: a primary income statement summary and a secondary table for adjusting items, accompanied by four callout boxes explaining the financial performance.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations Beat · Action1 hit
35
CER likely stands for Constant Exchange Rate.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations 1 hit
36
CER likely stands for Constant Exchange Rate.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations 1 hit